advertisement

---

Zhao S 11

Showing records 1 to 11 | Display all abstracts from Zhao S

127269 A multi-omics study reveals molecular characteristics and therapeutic targets of salidroside in reducing TGF-β2-induced ECM expression
Zhang R
Experimental Eye Research 2025; 256: 110386

---

128792 Adverse events associated with four atypical antipsychotics used as augmentation treatment for major depressive disorder: A pharmacovigilance study based on the FAERS database
Qi F; Tian L
Journal of Affective Disorders 2025; 388: 119435

---

127269 A multi-omics study reveals molecular characteristics and therapeutic targets of salidroside in reducing TGF-β2-induced ECM expression
Li N
Experimental Eye Research 2025; 256: 110386

---

128792 Adverse events associated with four atypical antipsychotics used as augmentation treatment for major depressive disorder: A pharmacovigilance study based on the FAERS database
Diao H
Journal of Affective Disorders 2025; 388: 119435

---

127269 A multi-omics study reveals molecular characteristics and therapeutic targets of salidroside in reducing TGF-β2-induced ECM expression
Fan Y; Qing D
Experimental Eye Research 2025; 256: 110386

---

128792 Adverse events associated with four atypical antipsychotics used as augmentation treatment for major depressive disorder: A pharmacovigilance study based on the FAERS database
Zhao S; Li F
Journal of Affective Disorders 2025; 388: 119435

---

127269 A multi-omics study reveals molecular characteristics and therapeutic targets of salidroside in reducing TGF-β2-induced ECM expression
Zhao S
Experimental Eye Research 2025; 256: 110386

---

128792 Adverse events associated with four atypical antipsychotics used as augmentation treatment for major depressive disorder: A pharmacovigilance study based on the FAERS database
Zhang Y
Journal of Affective Disorders 2025; 388: 119435

---

127269 A multi-omics study reveals molecular characteristics and therapeutic targets of salidroside in reducing TGF-β2-induced ECM expression
Ren X; Wang A
Experimental Eye Research 2025; 256: 110386

---

128792 Adverse events associated with four atypical antipsychotics used as augmentation treatment for major depressive disorder: A pharmacovigilance study based on the FAERS database
Qu M; Zhang X
Journal of Affective Disorders 2025; 388: 119435

---

127269 A multi-omics study reveals molecular characteristics and therapeutic targets of salidroside in reducing TGF-β2-induced ECM expression
Gao Z
Experimental Eye Research 2025; 256: 110386

---